On this paper, we current new knowledge on the genus Macrosaldula Leston Southwood, 1964 primarily based on materials held within the collections of the Nationwide Museum (Prague, Czech Republic) and the Zoological Institute of the Russian Academy of Sciences (St. Petersburg, Russia). Macrosaldula graziae sp. nov., from South Uzbekistan and Tajikistan, is described.
Among the many Central Asian species of the genus, it’s near M. tadzhika (Kiritshenko, 1912) by the presence of lengthy erect setae on the physique dorsum, however the latter species differs within the smaller physique dimension, the presence of sunshine spots on the corium, and within the construction of the male genitalia.
In extraordinarily darkish specimens of M. jakowleffi (Reuter, 1891), the hemelytra are opaque, with brief erect setae. Siberian M. rivularia (J. Sahlberg, 1878), M. simulans Cobben, 1985 and the Far Jap M. koreana (Kiritshenko, 1912) and M. violacea Cobben, 1985 are distinguished from the brand new species by the brief pubescence on the dorsum.
We offer new distributional knowledge for M. clavalis Cobben, 1985 (Georgia), M. jakowleffi (Reuter, 1891) (China: Xinjiang: Altai Mts.-first file), M. miyamotoi Cobben, 1985 (Japan: Honshu), M. nivalis (Lindberg, 1935) (Afghanistan-first file, Kyrgyzstan, Tajikistan), M. scotica (Curtis, 1835) (Georgia: Adzharia; Russia: Murmansk District), and M. tadzhika (Afghanistan-first file, Tajikistan, Uzbekistan). The file of M. scotica from Uzbekistan is disconsidered, and the 2 specimens are referred to M. graziae sp. nov.
Inherited glycosylphosphatidylinositol defects trigger the uncommon Emm-negative blood phenotype and developmental issues
Glycosylphosphatidylinositol (GPI) is a glycolipid that anchors greater than 150 proteins to the cell floor. Pathogenic variants in a number of genes that take part in GPI biosynthesis trigger inherited GPI deficiency (IGD) issues. Right here, we reported that homozygous null alleles of PIGG, a gene concerned in GPI modification, are accountable for the uncommon Emm-negative blood phenotype.
Utilizing a panel of Okay562 cells faulty in each the GPI-transamidase and GPI transforming pathways, we reveal that the Emm antigen, whose molecular foundation has remained unknown for many years, is carried solely by free GPI and that its epitope consists of the second and third ethanolamine of the GPI spine. Importantly, we present that the lower in Emm expression in a number of IGD sufferers is indicative of GPI defects. Total, our findings set up Emm as a novel blood group system and have vital implications for understanding the organic operate of human free GPI.
Environmental Multimedia Modeling System (EMMS) for Well being Danger Evaluation: Key Influencing Elements and Uncertainties Researches
On this paper, a former developed Environmental Multimedia Modeling System (EMMS) combining with threat evaluation Monte Carlo Technique (MCM) was additional used for exploring the interplay between groundwater and floor water. When utilizing this EMMS-MCM simulation, this paper consider combining a number of influencing components on its permeability coefficient and different parameters, reminiscent of hydraulic conductivity, density, recharge, layers, and depth.
These influencing components are key components to the unsure pure geological media and hydrographical components, inflicting huge challenges associated to the optimum allocation of water. Particularly, the system working with an EMMS-MCM simulation mixed with Danger Quotient (RQ) would be the supply of quantitative evaluation and analysis of environmental threat hazards, and the environmental threat hazards are inside the acceptable vary when contemplating optimum water allocation.
The EMMS-MCM is verified and analyzed by evaluating the info of hazardous websites with the investigation outcomes contemplating these influencing components. A case research of benzene emissions from Path Street Landfill Website reveals that the higher and center aquifers circulate within the northwest route. Within the south and close to the west of the Path Street landfill, groundwater flows north. About 60% of the expected focus of benzene falls inside the vary of 1.15E-6 to 2.65E-6 kg/m3 .
RQ threat evaluation for the groundwater signifies that threat stage lower from 2016 to 2026. The usage of EMMS-MCM simulation will assist to make hazardous area checks and future environmental administration as affordable as potential and allow one to foretell the potential penalties of hazardous groundwater contamination after contemplating some water allocation components.
The mixing of the EMMS-MCM and RQ would be the greatest instrument for a quicker and extra correct evaluation of the long-term dangers to pollutant diffusion areas, particularly floor and groundwater environmental administration.
A potential survey of Streptococcus pyogenes infections in French Brittany from 2009 to 2017: Complete dynamic of latest emergent emm genotypes
Streptococcus pyogenes or group A Streptococcus (GAS) causes illnesses starting from uncomplicated pharyngitis to life-threatening infections. It has complicated epidemiology pushed by the variety, the temporal and geographical fluctuations of the circulating strains. Regardless of the worldwide burden of GAS illnesses, there may be at the moment no out there vaccination technique in opposition to GAS infections.
This research, primarily based on a longitudinal inhabitants survey, aimed to know the dynamic of GAS emm sorts and to offer results in higher recognition of underlying mechanisms for the emergence of profitable clones. From 2009 to 2017, we performed a scientific culture-based analysis of GAS infections in a French Brittany inhabitants with a potential restoration of medical knowledge.
The epidemiological evaluation was carried out utilizing emm typing mixed with the structural and purposeful cluster-typing system for all of the recovered strains. Danger components for the invasiveness, recognized by univariate evaluation, had been computed in a a number of logistic regression evaluation, and the one unbiased threat issue remaining within the mannequin was the age (OR for the complete vary [CI95%] = 6.35 [3.63, 11.10]; p<0.0001).
Among the many 61 totally different emm sorts recognized, essentially the most prevalent had been emm28 (16%), emm89 (15%), emm1 (14%), and emm4 (8%), which accounted for greater than 50% of circulating strains. In the course of the research interval, 5 genotypes recognized as emm44, 66, 75, 83, 87 emerged successively and belonged to clusters D4, E2, E3, and E6 that had been totally different from these gathering “Prevalent” emm sorts (clusters A-C3 to five, E1 and E4).
Anti-Hu CD147 Biotin |
|||
| 1B-274-C025 | ExBio | 0.025 mg | 146.4 EUR |
Anti-Hu CD147 Biotin |
|||
| 1B-274-C100 | ExBio | 0.1 mg | 244.8 EUR |
Anti-Hu CD147 Purified |
|||
| 11-274-C025 | ExBio | 0.025 mg | 124.8 EUR |
Anti-Hu CD147 Purified |
|||
| 11-274-C100 | ExBio | 0.1 mg | 200.4 EUR |
Anti-Hu CD147 Purified |
|||
| 11-454-C025 | ExBio | 0.025 mg | 124.8 EUR |
Anti-Hu CD147 Purified |
|||
| 11-454-C100 | ExBio | 0.1 mg | 200.4 EUR |
Mouse Anti Human Cd147 Monoclonal Antibody,AZIDE FREE |
|||
| CABT-47078MH | Creative Diagnostics | 0.1 mg | 795.6 EUR |
Mouse Monoclonal Anti-Human CD147, Unlabeled |
|||
| CD147UL-100 | Alpha Diagnostics | 100 ug | 489.6 EUR |
Anti Human CD147 (EMMPRIN) Monoclonal Antibody (Clone No.2G2) |
|||
| KS130 | Sceti | each | 856.8 EUR |
|
Description: The Anti Human CD147 (EMMPRIN) Monoclonal Antibody (Clone No.2G2) is available in Europe and for worldwide shipping via Gentaur. |
|||
Human CD147 ELISA Kit |
|||
| EHC0241 | Abclonal | 96Tests | 625.2 EUR |
Anti-Hu CD147 Alexa Fluor488 |
|||
| A4-274-T025 | ExBio | 25 tests | 184.8 EUR |
Anti-Hu CD147 Alexa Fluor488 |
|||
| A4-274-T100 | ExBio | 100 tests | 322.8 EUR |
CD147 ELISA KIT|Human |
|||
| EF006740 | Lifescience Market | 96 Tests | 826.8 EUR |
Mouse Monoclonal Anti-Human CD147-PE conjugate |
|||
| CD147P-100 | Alpha Diagnostics | 100 Tests | 562.8 EUR |
Mouse Monoclonal Anti-Human CD147-FITC conjugate |
|||
| CD147F-100 | Alpha Diagnostics | 100 Tests | 562.8 EUR |
CD147 |
|||
| 147A1-100T | ImmunoStep | 100 test | 418.8 EUR |
CD147 |
|||
| 147CFB1-100T | ImmunoStep | 100 test | 465.6 EUR |
CD147 |
|||
| 147F1-100T | ImmunoStep | 100 test | 356.4 EUR |
CD147 |
|||
| 147P1E-100T | ImmunoStep | 100 test | 418.8 EUR |
CD147 |
|||
| 147PE2-100T | ImmunoStep | 100 test | 418.8 EUR |
CD147 |
|||
| 147PP1-100T | ImmunoStep | 100 test | 418.8 EUR |
CD147 |
|||
| 147PU1-01MG | ImmunoStep | 0,1 mg | 262.8 EUR |
Human CellExp? CD147, human recombinant |
|||
| 7455-10 | Biovision | each | 294 EUR |
Human CellExp? CD147, human recombinant |
|||
| 7455-50 | Biovision | each | 836.4 EUR |
CD147 antibody |
|||
| 10R-CD147aHU | Fitzgerald | 100 ug | 484.8 EUR |
|
Description: Mouse monoclonal CD147 antibody |
|||
CD147 Antibody |
|||
| AF0428 | Affbiotech | 200ul | 420 EUR |
CD147 Antibody |
|||
| AF5221 | Affbiotech | 200ul | 420 EUR |
CD147 Antibody |
|||
| 49372-100ul | SAB | 100ul | 399.6 EUR |
CD147 Antibody |
|||
| 49372-50ul | SAB | 50ul | 286.8 EUR |
CD147 antibody |
|||
| 70R-14065 | Fitzgerald | 100 ug | 386.4 EUR |
|
Description: Affinity purified Mouse polyclonal CD147 antibody |
|||
CD147 antibody |
|||
| 70R-31695 | Fitzgerald | 100 ug | 392.4 EUR |
|
Description: Rabbit polyclonal CD147 antibody |
|||
CD147 antibody |
|||
| 70R-51470 | Fitzgerald | 100 ul | 292.8 EUR |
|
Description: Purified Polyclonal CD147 antibody |
|||
CD147 Antibody |
|||
| ABD3164 | Lifescience Market | 100 ug | 525.6 EUR |
CD147 Antibody |
|||
| ABF0428 | Lifescience Market | 100 ug | 525.6 EUR |
CD147 Antibody |
|||
| ABF5221 | Lifescience Market | 100 ug | 525.6 EUR |
CD147 Antibody |
|||
| DF6462 | Affbiotech | 200ul | 420 EUR |
CD147 Antibody |
|||
| R30601 | NSJ Bioreagents | 100 ug | 356.15 EUR |
|
Description: Emmprin, extracellular matrix metalloproteinase inducer, also known as Emmprin(BSG) or cluster of differentiation 147 is a protein that in humans is encoded by the Emmprin gene. The gene contains 8 exons and spans 10.8 kb. This protein is a determinant for the Ok blood group system. CD147 has been shown to be an essential receptor on red blood cells for the malaria parasite. It is a member of the immunoglobulin superfamily, with a structure related to the putative primordial form of the family. As members of the immunoglobulin superfamily play fundamental roles in intercellular recognition involved in various immunologic phenomena, differentiation, and development, It is though also to play a role in intercellular recognition. CD147 also regulates several distinct functions, such as spermatogenesis, expression of the monocarboxylate transporter and the responsiveness of lymphocytes. It is a type I integral membrane receptor that has many ligands, including the cyclophilin(CyP) proteins Cyp-A and CyP-B and certain integrins. It is expressed by many cell types, including epithelial cells, endothelial cells and leukocytes. |
|||
CD147 Antibody |
|||
| R31660 | NSJ Bioreagents | 100 ug | 356.15 EUR |
|
Description: Cluster of differentiation 147 is a member of the immunoglobulin superfamily, with a structure related to the putative primordial form of the family. As members of the immunoglobulin superfamily, it plays fundamental roles in intercellular recognition involved in various immunologic phenomena, differentiation, and development. CD147 is thought also to play a role in intercellular recognition. It also regulates several distinct functions, such as spermatogenesis, expression of the monocarboxylate transporter and the responsiveness of lymphocytes. |
|||
Mouse Anti Rat Cd147 Monoclonal Antibody |
|||
| CABT-47096MR | Creative Diagnostics | 2 ml | 639.6 EUR |
PE Anti-human CD147 Antibody *MEM-M6/6* |
|||
| 114701K0 | AAT Bioquest | 25 tests | 383 EUR |
|
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn |
|||
PE Anti-human CD147 Antibody *MEM-M6/6* |
|||
| 114701K1 | AAT Bioquest | 100 tests | 995 EUR |
|
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn |
|||
PE Anti-human CD147 Antibody *MEM-M6/6* |
|||
| 114701K2 | AAT Bioquest | 500 tests | 2984 EUR |
|
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn |
|||
APC Anti-human CD147 Antibody *MEM-M6/6* |
|||
| 114701B0 | AAT Bioquest | 25 tests | 383 EUR |
|
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn |
|||
APC Anti-human CD147 Antibody *MEM-M6/6* |
|||
| 114701B1 | AAT Bioquest | 100 tests | 995 EUR |
|
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn |
|||
APC Anti-human CD147 Antibody *MEM-M6/6* |
|||
| 114701B2 | AAT Bioquest | 500 tests | 2984 EUR |
|
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn |
|||
FITC Anti-human CD147 Antibody *MEM-M6/6* |
|||
| 114701G0 | AAT Bioquest | 100 tests | 547 EUR |
|
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn |
|||
FITC Anti-human CD147 Antibody *MEM-M6/6* |
|||
| 114701G1 | AAT Bioquest | 500 tests | 2051 EUR |
|
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn |
|||
TRITC Anti-human CD147 Antibody *MEM-M6/6* |
|||
| 114701H0 | AAT Bioquest | 100 tests | 547 EUR |
|
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn |
|||
TRITC Anti-human CD147 Antibody *MEM-M6/6* |
|||
| 114701H1 | AAT Bioquest | 500 tests | 2051 EUR |
|
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn |
|||
PerCP Anti-human CD147 Antibody *MEM-M6/6* |
|||
| 114701S0 | AAT Bioquest | 25 tests | 383 EUR |
|
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn |
|||
PerCP Anti-human CD147 Antibody *MEM-M6/6* |
|||
| 114701S1 | AAT Bioquest | 100 tests | 995 EUR |
|
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn |
|||
PerCP Anti-human CD147 Antibody *MEM-M6/6* |
|||
| 114701S2 | AAT Bioquest | 500 tests | 2984 EUR |
|
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn |
|||
Human CD147/EMMPRIN ELISA kit |
|||
| E01C0234-192T | BlueGene | 192 tests | 1524 EUR |
|
Description: A competitive ELISA for quantitative measurement of Human CD147/EMMPRIN in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Human CD147/EMMPRIN ELISA kit |
|||
| E01C0234-48 | BlueGene | 1 plate of 48 wells | 624 EUR |
|
Description: A competitive ELISA for quantitative measurement of Human CD147/EMMPRIN in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Human CD147/EMMPRIN ELISA kit |
|||
| E01C0234-96 | BlueGene | 1 plate of 96 wells | 822 EUR |
|
Description: A competitive ELISA for quantitative measurement of Human CD147/EMMPRIN in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Human CD147/EMMPRIN ELISA Kit |
|||
| EHE0043 | Abclonal | 96Tests | 625.2 EUR |
PacBlue Anti-human CD147 Antibody *MEM-M6/6* |
|||
| 114701I0 | AAT Bioquest | 100 tests | 547 EUR |
|
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn |
|||
PacBlue Anti-human CD147 Antibody *MEM-M6/6* |
|||
| 114701I1 | AAT Bioquest | 500 tests | 2051 EUR |
|
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn |
|||
Purified Anti-human CD147 Antibody *MEM-M6/6* |
|||
| 11470000 | AAT Bioquest | 100 ug | 365 EUR |
|
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn |
|||
Anti-Hu CD147 Purified Low Endotoxin |
|||
| 12-507-C100 | ExBio | 0.1 mg | 200.4 EUR |
PacOrange Anti-human CD147 Antibody *MEM-M6/6* |
|||
| 114701J0 | AAT Bioquest | 100 tests | 547 EUR |
|
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn |
|||
PacOrange Anti-human CD147 Antibody *MEM-M6/6* |
|||
| 114701J1 | AAT Bioquest | 500 tests | 2051 EUR |
|
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn |
|||
Human Emmprin / CD147 ELISA kit |
|||
| LF-EK50719 | Abfrontier | 1×96T | 777.6 EUR |
Mouse Monoclonal Anti-Human CD147-PE-Cy5-conjugate |
|||
| CD147PC-100 | Alpha Diagnostics | 100 Tests | 562.8 EUR |
PE/Cy5 Anti-human CD147 Antibody *MEM-M6/6* |
|||
| 114701L0 | AAT Bioquest | 25 tests | 429 EUR |
|
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn |
|||
PE/Cy5 Anti-human CD147 Antibody *MEM-M6/6* |
|||
| 114701L1 | AAT Bioquest | 100 tests | 1117 EUR |
|
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn |
|||
PE/Cy5 Anti-human CD147 Antibody *MEM-M6/6* |
|||
| 114701L2 | AAT Bioquest | 500 tests | 3351 EUR |
|
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn |
|||
PE/Cy7 Anti-human CD147 Antibody *MEM-M6/6* |
|||
| 114701M0 | AAT Bioquest | 25 tests | 429 EUR |
|
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn |
|||
PE/Cy7 Anti-human CD147 Antibody *MEM-M6/6* |
|||
| 114701M1 | AAT Bioquest | 100 tests | 1117 EUR |
|
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn |
|||
PE/Cy7 Anti-human CD147 Antibody *MEM-M6/6* |
|||
| 114701M2 | AAT Bioquest | 500 tests | 3351 EUR |
|
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn |
|||
APC/Cy7 Anti-human CD147 Antibody *MEM-M6/6* |
|||
| 114701C0 | AAT Bioquest | 25 tests | 429 EUR |
|
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn |
|||
APC/Cy7 Anti-human CD147 Antibody *MEM-M6/6* |
|||
| 114701C1 | AAT Bioquest | 100 tests | 1117 EUR |
|
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn |
|||
APC/Cy7 Anti-human CD147 Antibody *MEM-M6/6* |
|||
| 114701C2 | AAT Bioquest | 500 tests | 3351 EUR |
|
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn |
|||
PerCP/Cy5.5 Anti-human CD147 Antibody *MEM-M6/6* |
|||
| 114701T0 | AAT Bioquest | 25 tests | 429 EUR |
|
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn |
|||
PerCP/Cy5.5 Anti-human CD147 Antibody *MEM-M6/6* |
|||
| 114701T1 | AAT Bioquest | 100 tests | 1117 EUR |
|
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn |
|||
PerCP/Cy5.5 Anti-human CD147 Antibody *MEM-M6/6* |
|||
| 114701T2 | AAT Bioquest | 500 tests | 3351 EUR |
|
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn |
|||
Rat Anti Mouse Cd147 Monoclonal Antibody,RPE |
|||
| CABT-47093RM | Creative Diagnostics | 100 TEST | 639.6 EUR |
CD147 antibody (PE) |
|||
| 61R-1311 | Fitzgerald | 50 ug | 249.6 EUR |
|
Description: Rat monoclonal CD147 antibody (PE) |
|||
CD147 antibody (PE) |
|||
| 61R-CD147aHUPE | Fitzgerald | 120 tests | 703.2 EUR |
|
Description: Mouse monoclonal CD147 antibody (PE) |
|||
Rat Anti Mouse Cd147 Monoclonal Antibody,FITC |
|||
| CABT-47088RM | Creative Diagnostics | 0.1 mg | 546 EUR |
Mouse Anti Rat Cd147 Monoclonal Antibody,FITC |
|||
| CABT-47094MR | Creative Diagnostics | 0.1 mg | 651.6 EUR |
CD147(8D6) Antibody |
|||
| BNCA0424-250 | Biotium | 250uL | 459.6 EUR |
|
Description: Primary antibody against CD147(8D6), APC conjugate, Concentration: 0.1mg/mL |
|||
CD147(8D6) Antibody |
|||
| BNC800424-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against CD147(8D6), CF680 conjugate, Concentration: 0.1mg/mL |
|||
CD147(8D6) Antibody |
|||
| BNC800424-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against CD147(8D6), CF680 conjugate, Concentration: 0.1mg/mL |
|||
CD147(8D6) Antibody |
|||
| BNC810424-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against CD147(8D6), CF680R conjugate, Concentration: 0.1mg/mL |
|||
CD147(8D6) Antibody |
|||
| BNC810424-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against CD147(8D6), CF680R conjugate, Concentration: 0.1mg/mL |
|||
CD147(8D6) Antibody |
|||
| BNC940424-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against CD147(8D6), CF594 conjugate, Concentration: 0.1mg/mL |
|||
CD147(8D6) Antibody |
|||
| BNC940424-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against CD147(8D6), CF594 conjugate, Concentration: 0.1mg/mL |
|||
CD147(8D6) Antibody |
|||
| BNC700424-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against CD147(8D6), CF770 conjugate, Concentration: 0.1mg/mL |
|||
CD147(8D6) Antibody |
|||
| BNC700424-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against CD147(8D6), CF770 conjugate, Concentration: 0.1mg/mL |
|||
CD147(8D6) Antibody |
|||
| BNC880424-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against CD147(8D6), CF488A conjugate, Concentration: 0.1mg/mL |
|||
CD147(8D6) Antibody |
|||
| BNC880424-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against CD147(8D6), CF488A conjugate, Concentration: 0.1mg/mL |
|||
CD147(8D6) Antibody |
|||
| BNC400424-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against CD147(8D6), CF640R conjugate, Concentration: 0.1mg/mL |
|||
CD147(8D6) Antibody |
|||
| BNC400424-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against CD147(8D6), CF640R conjugate, Concentration: 0.1mg/mL |
|||
CD147(8D6) Antibody |
|||
| BNC050424-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against CD147(8D6), CF405M conjugate, Concentration: 0.1mg/mL |
|||
CD147(8D6) Antibody |
|||
| BNC050424-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against CD147(8D6), CF405M conjugate, Concentration: 0.1mg/mL |
|||
CD147(8D6) Antibody |
|||
| BNCB0424-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against CD147(8D6), Biotin conjugate, Concentration: 0.1mg/mL |
|||
CD147(8D6) Antibody |
|||
| BNCB0424-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against CD147(8D6), Biotin conjugate, Concentration: 0.1mg/mL |
|||
CD147(8D6) Antibody |
|||
| BNCAP0424-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against CD147(8D6), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
CD147(8D6) Antibody |
|||
| BNCAP0424-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against CD147(8D6), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
CD147(8D6) Antibody |
|||
| BNCR0424-250 | Biotium | 250uL | 459.6 EUR |
|
Description: Primary antibody against CD147(8D6), RPE conjugate, Concentration: 0.1mg/mL |
|||
CD147(8D6) Antibody |
|||
| BNCP0424-250 | Biotium | 250uL | 459.6 EUR |
|
Description: Primary antibody against CD147(8D6), PerCP conjugate, Concentration: 0.1mg/mL |
|||
CD147(8D6) Antibody |
|||
| BNUM0424-50 | Biotium | 50uL | 474 EUR |
|
Description: Primary antibody against CD147(8D6), 1mg/mL |
|||
CD147(8D6) Antibody |
|||
| BNCH0424-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against CD147(8D6), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
CD147(8D6) Antibody |
|||
| BNCH0424-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against CD147(8D6), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
CD147(8D6) Antibody |
|||
| BNUB0424-100 | Biotium | 100uL | 250.8 EUR |
|
Description: Primary antibody against CD147(8D6), Concentration: 0.2mg/mL |
|||
CD147(8D6) Antibody |
|||
| BNUB0424-500 | Biotium | 500uL | 549.6 EUR |
|
Description: Primary antibody against CD147(8D6), Concentration: 0.2mg/mL |
|||
CD147(8D6) Antibody |
|||
| BNC040424-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against CD147(8D6), CF405S conjugate, Concentration: 0.1mg/mL |
|||
CD147(8D6) Antibody |
|||
| BNC040424-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against CD147(8D6), CF405S conjugate, Concentration: 0.1mg/mL |
|||
CD147(8D6) Antibody |
|||
| BNC550424-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against CD147(8D6), CF555 conjugate, Concentration: 0.1mg/mL |
|||
CD147(8D6) Antibody |
|||
| BNC550424-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against CD147(8D6), CF555 conjugate, Concentration: 0.1mg/mL |
|||
CD147(8D6) Antibody |
|||
| BNC610424-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against CD147(8D6), CF660R conjugate, Concentration: 0.1mg/mL |
|||
CD147(8D6) Antibody |
|||
| BNC610424-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against CD147(8D6), CF660R conjugate, Concentration: 0.1mg/mL |
|||
CD147(8D6) Antibody |
|||
| BNC680424-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against CD147(8D6), CF568 conjugate, Concentration: 0.1mg/mL |
|||
CD147(8D6) Antibody |
|||
| BNC680424-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against CD147(8D6), CF568 conjugate, Concentration: 0.1mg/mL |
|||
CD147(8D6) Antibody |
|||
| BNC470424-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against CD147(8D6), CF647 conjugate, Concentration: 0.1mg/mL |
|||
CD147(8D6) Antibody |
|||
| BNC470424-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against CD147(8D6), CF647 conjugate, Concentration: 0.1mg/mL |
|||
CD147(8D6) Antibody |
|||
| BNC430424-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against CD147(8D6), CF543 conjugate, Concentration: 0.1mg/mL |
|||
CD147(8D6) Antibody |
|||
| BNC430424-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against CD147(8D6), CF543 conjugate, Concentration: 0.1mg/mL |
|||
Rat Anti Mouse Cd147 Monoclonal Antibody,Biotin |
|||
| CABT-47085RM | Creative Diagnostics | 0.1 mg | 514.8 EUR |
CD147 Antibody (FITC) |
|||
| abx139075-100tests | Abbexa | 100 tests | 510 EUR |
CD147 Antibody (FITC) |
|||
| abx200502-100tests | Abbexa | 100 tests | 477.6 EUR |
CD147 Antibody (FITC) |
|||
| abx133900-100Assays | Abbexa | 100 Assays | 526.8 EUR |
CD147 Antibody (FITC) |
|||
| abx133900-50Assays | Abbexa | 50 Assays | 410.4 EUR |
CD147(CB43) Antibody |
|||
| BNCA0363-250 | Biotium | 250uL | 459.6 EUR |
|
Description: Primary antibody against CD147(CB43), APC conjugate, Concentration: 0.1mg/mL |
|||
CD147(CB43) Antibody |
|||
| BNC800363-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against CD147(CB43), CF680 conjugate, Concentration: 0.1mg/mL |
|||
CD147(CB43) Antibody |
|||
| BNC800363-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against CD147(CB43), CF680 conjugate, Concentration: 0.1mg/mL |
|||
CD147(CB43) Antibody |
|||
| BNC810363-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against CD147(CB43), CF680R conjugate, Concentration: 0.1mg/mL |
|||
CD147(CB43) Antibody |
|||
| BNC810363-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against CD147(CB43), CF680R conjugate, Concentration: 0.1mg/mL |
|||
CD147(CB43) Antibody |
|||
| BNC940363-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against CD147(CB43), CF594 conjugate, Concentration: 0.1mg/mL |
|||
CD147(CB43) Antibody |
|||
| BNC940363-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against CD147(CB43), CF594 conjugate, Concentration: 0.1mg/mL |
|||
CD147(CB43) Antibody |
|||
| BNC700363-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against CD147(CB43), CF770 conjugate, Concentration: 0.1mg/mL |
|||
CD147(CB43) Antibody |
|||
| BNC700363-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against CD147(CB43), CF770 conjugate, Concentration: 0.1mg/mL |
|||
CD147(CB43) Antibody |
|||
| BNC430363-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against CD147(CB43), CF543 conjugate, Concentration: 0.1mg/mL |
|||
CD147(CB43) Antibody |
|||
| BNC430363-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against CD147(CB43), CF543 conjugate, Concentration: 0.1mg/mL |
|||
CD147(CB43) Antibody |
|||
| BNC400363-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against CD147(CB43), CF640R conjugate, Concentration: 0.1mg/mL |
|||
CD147(CB43) Antibody |
|||
| BNC400363-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against CD147(CB43), CF640R conjugate, Concentration: 0.1mg/mL |
|||
CD147(CB43) Antibody |
|||
| BNC050363-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against CD147(CB43), CF405M conjugate, Concentration: 0.1mg/mL |
|||
CD147(CB43) Antibody |
|||
| BNC050363-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against CD147(CB43), CF405M conjugate, Concentration: 0.1mg/mL |
|||
CD147(CB43) Antibody |
|||
| BNCB0363-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against CD147(CB43), Biotin conjugate, Concentration: 0.1mg/mL |
|||
CD147(CB43) Antibody |
|||
| BNCB0363-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against CD147(CB43), Biotin conjugate, Concentration: 0.1mg/mL |
|||
CD147(CB43) Antibody |
|||
| BNCAP0363-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against CD147(CB43), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
CD147(CB43) Antibody |
|||
| BNCAP0363-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against CD147(CB43), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
CD147(CB43) Antibody |
|||
| BNC880363-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against CD147(CB43), CF488A conjugate, Concentration: 0.1mg/mL |
|||
CD147(CB43) Antibody |
|||
| BNC880363-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against CD147(CB43), CF488A conjugate, Concentration: 0.1mg/mL |
|||
CD147(CB43) Antibody |
|||
| BNCR0363-250 | Biotium | 250uL | 459.6 EUR |
|
Description: Primary antibody against CD147(CB43), RPE conjugate, Concentration: 0.1mg/mL |
|||
CD147(CB43) Antibody |
|||
| BNCP0363-250 | Biotium | 250uL | 459.6 EUR |
|
Description: Primary antibody against CD147(CB43), PerCP conjugate, Concentration: 0.1mg/mL |
|||
CD147(CB43) Antibody |
|||
| BNUM0363-50 | Biotium | 50uL | 474 EUR |
|
Description: Primary antibody against CD147(CB43), 1mg/mL |
|||
CD147(CB43) Antibody |
|||
| BNCH0363-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against CD147(CB43), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
CD147(CB43) Antibody |
|||
| BNCH0363-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against CD147(CB43), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
CD147(CB43) Antibody |
|||
| BNUB0363-100 | Biotium | 100uL | 250.8 EUR |
|
Description: Primary antibody against CD147(CB43), Concentration: 0.2mg/mL |
|||
CD147(CB43) Antibody |
|||
| BNUB0363-500 | Biotium | 500uL | 549.6 EUR |
|
Description: Primary antibody against CD147(CB43), Concentration: 0.2mg/mL |
|||
CD147(CB43) Antibody |
|||
| BNC040363-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against CD147(CB43), CF405S conjugate, Concentration: 0.1mg/mL |
|||
CD147(CB43) Antibody |
|||
| BNC040363-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against CD147(CB43), CF405S conjugate, Concentration: 0.1mg/mL |
|||
CD147(CB43) Antibody |
|||
| BNC550363-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against CD147(CB43), CF555 conjugate, Concentration: 0.1mg/mL |
|||
CD147(CB43) Antibody |
|||
| BNC550363-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against CD147(CB43), CF555 conjugate, Concentration: 0.1mg/mL |
|||
CD147(CB43) Antibody |
|||
| BNC610363-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against CD147(CB43), CF660R conjugate, Concentration: 0.1mg/mL |
|||
CD147(CB43) Antibody |
|||
| BNC610363-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against CD147(CB43), CF660R conjugate, Concentration: 0.1mg/mL |
|||
CD147(CB43) Antibody |
|||
| BNC680363-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against CD147(CB43), CF568 conjugate, Concentration: 0.1mg/mL |
|||
CD147(CB43) Antibody |
|||
| BNC680363-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against CD147(CB43), CF568 conjugate, Concentration: 0.1mg/mL |
|||
CD147(CB43) Antibody |
|||
| BNC470363-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against CD147(CB43), CF647 conjugate, Concentration: 0.1mg/mL |
|||
CD147(CB43) Antibody |
|||
| BNC470363-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against CD147(CB43), CF647 conjugate, Concentration: 0.1mg/mL |
|||
CD147 Antibody (Biotin) |
|||
| abx139074-01mg | Abbexa | 0.1 mg | 510 EUR |
CD147 Antibody (Biotin) |
|||
| abx021360-100ug | Abbexa | 100 ug | 661.2 EUR |
CD147 antibody (biotin) |
|||
| 61R-CD147aHUBT | Fitzgerald | 100 ug | 495.6 EUR |
|
Description: Mouse monoclonal CD147 antibody (biotin) |
|||
Basigin (CD147) Antibody |
|||
| abx139069-01mg | Abbexa | 0.1 mg | 444 EUR |
We beforehand reported vital genetic modifications for emm44, 66, 83 and 75 sorts ensuing probably from a brief adaptive evolution. Herein we moreover noticed that the emergence of a brand new genotype may happen in a prone inhabitants having particular threat components or in all probability missing a naturally-acquired cluster-specific immune cross-protection. Amongst emergent emm sorts, emm75 and emm87 are inclined to grow to be prevalent with a steady annual incidence and the danger of a clonal growth need to be thought of.